Immix Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $22.9M
Liabilities Breakdown FY2024
Total Liabilities: $9.7M
Asset Breakdown
Total Assets: $22.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $17.7M | 77.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.7M | 7.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $3.5M | 15.4% |
Liabilities Breakdown
Total Liabilities: $9.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.4M | 55.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $4.3M | 44.4% |